logo
New sea base, tech upgrades for Sabah's Op Pasir

New sea base, tech upgrades for Sabah's Op Pasir

KUALA LUMPUR: AN operation on the eastern coast of Sabah is undergoing a major transformation by leveraging advanced surveillance technology, real-time intelligence systems and community-based reporting.
Joint Forces Commander Lieutenant-General Datuk Zahani Zainal Abidin said Op Pasir had significantly expanded the use of unmanned aerial vehicles (UAVs), coastal radar, and closed-circuit television systems to boost domain awareness and detection capabilities in the Eastern Sabah Security Zone (ESS Zone).
"Enhancements to the Coastal Surveillance System would allow for earlier detection of suspicious vessel movements."
These upgrades, he said, formed part of Op Pasir's evolution into a tech-driven, multi-agency defence operation supported by real-time coordination between the military, police and maritime enforcement.
A cornerstone of this technological shift is the introduction of the Multi Purpose Command Platform (MPCP) — a mobile sea base that will replace the ageing Tun Sharifah Rodziah Sea Base.
"The MPCP is a Mobile Forward Operating Base designed to replace the existing PL Tun Sharifah Rodziah.
"This platform is capable of long-duration operations and can be rapidly deployed to hotspot areas," Zahani said.
With capabilities to operate helicopters, interception boats, UAVs and unmanned surface vehicles, the MPCP will serve as a launch base for Quick Reaction Force teams — drastically cutting response time to smuggling attempts, incursions and maritime criminal activity.
"With the deployment of this asset, Op Pasir is expected to be conducted more efficiently and effectively, enhancing operational readiness and territorial control," Zahani said.
COLLABORATIVE EFFORT
First launched 25 years ago, Op Pasir is today a full-spectrum joint operation led by the Joint Forces Headquarters and executed by Joint Forces Command 2.
It involves a full-strength armed forces deployment across the ESS Zone districts of Kudat, Sandakan, Lahad Datu and Semporna.
Troops maintain a round-the-clock presence on 21 islands and 19 land-based security posts, supported by maritime patrols, land-based security sweeps and aerial surveillance conducted by the Royal Malaysian Air Force.
"Through this integrated deployment, Op Pasir has significantly enhanced domain awareness, response time and deterrence against threats such as piracy, smuggling, cross-border intrusions and maritime terrorism in one of Malaysia's most strategically-sensitive regions," Zahani said.
Operational results last year and this year reflect the effectiveness of the approach, with 11 undocumented immigrants detained in Semporna waters and multiple seizures of controlled contraband, particularly petrol and diesel, that were handed over to police for further action.
"These enforcement results highlight the effectiveness of Op Pasir's patrols, thus enhancing security and law enforcement in Malaysia's maritime domain," Zahani said.
Beyond tactical upgrades, Op Pasir has undergone structural reforms to improve inter-agency cooperation and community engagement.
"Op Pasir now operates with a more structured collaboration among the armed forces, police, Malaysian Maritime Enforcement Agency and the Eastern Sabah Security Command (Esscom)," Zahani said.
"The establishment of joint operations centers and real-time intelligence sharing has enabled faster and more effective responses to threats."
COMMUNITY-BASED APPROACH
Meanwhile, public involvement has been strengthened through programmes like Community Policing and Rakan Maritim (Maritime Friends), empowering local residents to report suspicious activity.
"A community-based approach has become a core element of Op Pasir. Safety education and cooperation with community leaders foster awareness of security risks and promote timely reporting of suspicious activities," Zahani said.
However, he stressed that the operation's impact went well beyond security.
"By maintaining continuous security control over Sabah's maritime and land borders, Op Pasir fosters a stable environment free from intrusions, piracy and cross-border crimes.
"This stability is essential for encouraging both domestic and foreign investments, thereby supporting the sustained economic and social development of local communities."
"The ESS Zone encompasses key economic areas including fisheries zones, commercial ports and strategic project sites.
"Through integrated monitoring and patrols, Op Pasir safeguards these critical assets from sabotage or external threats, ensuring uninterrupted national supply chains and protecting economic interests."
SENSE OF SECURITY
Zahani said a visible and sustained security presence helped enhance public trust and support broader government initiatives.
"The consistent presence of security personnel through Op Pasir demonstrates the government's commitment to the safety of its citizens.
"This effort boosts the sense of security within local communities and reinforces trust in the armed forces and other security agencies."
The broader outcome, he said, was a safer, more confident Sabah that could grow in tandem with Peninsular Malaysia.
"By securing the environment as a prerequisite for development, Op Pasir enables the smooth execution of government projects such as road construction, and improvements in education and healthcare facilities in rural areas."
"The improved security landscape resulting from Op Pasir not only benefits local communities and national development, but also enhances international confidence in East Malaysia.
"This growing trust is reflected in the increased tourism activities across Sabah, with visitors feeling safer to explore the region.
"Op Pasir is not merely a border security operation, but also a catalyst for continued stability and progress in East Malaysia.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges

Yahoo

time21 minutes ago

  • Yahoo

BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges

Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

Grupo de Inversiones Suramericana SA (GIVSY) Q2 2025 Earnings Call Highlights: Strong Profit ...
Grupo de Inversiones Suramericana SA (GIVSY) Q2 2025 Earnings Call Highlights: Strong Profit ...

Yahoo

time21 minutes ago

  • Yahoo

Grupo de Inversiones Suramericana SA (GIVSY) Q2 2025 Earnings Call Highlights: Strong Profit ...

Controlling Net Profit: COP1.2 trillion, up 34% compared to the same period last year. Operating Income: COP14.7 trillion, a 5% increase year-over-year. Operational Profit: COP2.7 trillion, up 13% from the previous year. Return on Equity: 11.7% over the last 12 months. Net Profit per Stock: COP6,000, a compound annual growth of 16% since 2019. Premiums Issued (Insurance): COP9.4 billion, a 3.1% increase. Technical Result (Insurance): COP1.2 trillion, up 10%. Net Profit (SURA Asset Management): COP600 billion, a 42% increase. Assets Under Management (AUM): COP781 billion, a 15% increase. Revenue from Commissions: COP2.1 trillion, up 9.4% in constant exchange rates. Net Profit (Grupo Cibest): COP3.5 trillion, up 14%. Equity Profitability (Grupo Cibest): 17.5% for the quarter. Dividends Expected: COP2.2 billion for the year. Warning! GuruFocus has detected 7 Warning Sign with GIVSY. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Grupo de Inversiones Suramericana SA (GIVSY) reported a controlling net profit of COP1.2 trillion for the first half of 2025, up 34% compared to the same period last year. The company's strategic spin-off process has resulted in a simpler structure, increased share liquidity, and higher stock capitalization, making it more attractive to institutional investors. Shareholders have seen significant appreciation in their investments, with common and preferred stocks increasing by 65% and 93%, respectively, since the spin-off. The company has a diversified financial services platform operating in over 10 countries, serving 76 million clients, which provides resilience and flexibility. Grupo SURA's financial services companies contributed COP1.8 billion to the results of the first six months of 2025, a 17% increase compared to 2024. Negative Points The casualty insurance segment experienced a 4% decrease in premiums issued, primarily due to the contraction of mandatory transit accident insurance in Colombia and increased price competition. The net profit for the casualty insurance segment significantly reduced compared to the previous year, driven by higher administrative expenses and restructuring costs. Grupo SURA's debt remains high at approximately COP7 billion, with plans to maintain this level by year-end, limiting financial flexibility. The company faces challenges in closing the gap between the fundamental value of its portfolio and market appreciation, despite efforts to increase visibility and liquidity. There is ongoing volatility in financial markets, which complicates predicting investment yields for the second half of the year, potentially impacting future profitability. Q & A Highlights Q: Considering the guidance for 2025 net profit was between COP1.7 trillion and COP1.9 trillion, and the results of the first semester, are you thinking about increasing the guidance? A: (Juan Esteban Tor, CFO) We see a pace of COP2 billion, and with the trends and observations in every company of the portfolio, this number is quite reachable. We have a good capability and are at that level for 2025. Q: How do you expect the evolution of the results, keeping in mind the pension reform? A: The results of protection have been evolving favorably. The company now has COP2 billion in AUMs, growing 12%. Revenue from commissions is growing double digits, and operating profit is growing above 40%. We are prepared to operationally work with the new parameters of the reform once it is in place. Q: How is the company planning to expand its insurance segment? A: (Juan Camilo Parra, Investment and Treasury Manager) Suramericana is focused on enhancing its value offer under two pillars: enhancing new business models and exploring underserved markets, such as Chile and Mexico, with health solutions. Q: What are you doing to close the gap between the common and preferred stock of Grupo SURA? A: (Ricardo Jaramillo Mejia, CEO) We aim to close the gap through profitable and efficient operations, increasing liquidity, floating, and eligibility of indexes. We have increased dividends and made the capital structure simpler, among other efforts. Q: What priorities does the group have to assign capital, and what can be expected from dividends in the future? A: We focus on debt reduction, increasing dividends, and investments. We moved from COP550 pesos per stock in 2019 to 1,500 now. Our priorities are to reduce debt and increase dividends, with investments left to Suramericana and SURA Asset Management. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Milestone Scientific Inc (MLSS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Driven ...
Milestone Scientific Inc (MLSS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Driven ...

Yahoo

time21 minutes ago

  • Yahoo

Milestone Scientific Inc (MLSS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Driven ...

Revenue: $2.3 million for Q2 2025, a 25% increase driven by dental segment performance. International Revenue: $1 million for Q2 2025, up from $489,000 in Q2 2024. Medical Revenue: $32,000 for Q2 2025, an increase from $19,000 in Q2 2024. Gross Profit: $1.6 million for Q2 2025, an increase of $206,000 from Q2 2024. Selling, General and Administrative Expenses: $3 million for Q2 2025, up from $2.9 million in Q2 2024. Research and Development Expenses: $52,000 for Q2 2025, down from $352,000 in Q2 2024. Loss from Operations: $1.5 million for Q2 2025, a decrease from $1.8 million in Q2 2024. Cash and Cash Equivalents: $1.3 million as of June 30, 2025. Working Capital: Approximately $3.9 million with no long-term debt. Cash Flows Used in Operating Activities: $2.8 million for the six months ended June 30, 2025. Warning! GuruFocus has detected 6 Warning Signs with MLSS. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Milestone Scientific Inc (MLSS) reported a 25% revenue growth in Q2 2025, reaching $2.3 million, primarily driven by the dental segment. The company secured Medicare Part B payment rate assignment under CPT code 0770T in multiple jurisdictions, enhancing reimbursement pathways for the CompuFlo Epidural System. International sales more than doubled, contributing significantly to the revenue increase, with international revenue accounting for 48% of total sales. The company has strengthened its leadership team with the appointment of Eric Hines as CEO and Jason Papes as Senior Vice President, Global Head of Sales and Marketing, both bringing extensive experience in scaling operations. Milestone Scientific Inc (MLSS) maintained a solid balance sheet with $1.3 million in cash and no long-term debt, indicating strong financial management. Negative Points Despite the Medicare Part B coverage, adoption of the CompuFlo system in the medical segment has been slow, with only 5 to 10 clinics actively using the product. Domestic dental sales were relatively flat, indicating challenges in growing the US market despite international success. The company reported a loss from operations of approximately $1.5 million for Q2 2025, although this was a decrease from the previous year. Research and development expenses decreased significantly, which could impact future innovation and product development. The company faces challenges with tariffs and international market dynamics, which could affect future growth and profitability. Q & A Highlights Q: Can you discuss the adoption of the CompuFlo system on the medical side, particularly with Medicare Part B coverage, and what steps are being taken to accelerate its adoption? A: Eric Hines, CEO: We currently have between 5 and 10 clinics using the product in the US. The focus is on reimbursement, collecting data, and ensuring doctors are reimbursed appropriately. We plan to invest in specialists to help with claims and data collection, focusing initially on a few clinics to confirm reimbursement processes before expanding further. Q: What are the plans for expanding the sales team under the new Head of Sales, Jason Papes? A: Eric Hines, CEO: Jason brings his prior distribution business, primarily focused in Texas. We are evaluating our current relationships with Axial and Shamrock. The focus will be on US-based sales, particularly in states where we have traction, and potentially hiring additional distribution as needed. Q: What drove the international revenue growth this quarter, and what percentage of total revenue did it represent? A: Keisha Harcum, VP, Finance: International revenue accounted for 48% of total revenue. Growth was driven by additional distributors, larger orders, and improved communication with distributors. The international business tends to be lumpy due to large orders from groups of customers. Q: How are tariffs affecting your international business, and what measures have you taken to mitigate their impact? A: Keisha Harcum, VP, Finance: Tariffs have not significantly impacted us. We have set up direct shipping from our warehouse in China to international partners and have sufficient inventory in the US to avoid tariff-related issues. Q: What is the strategy for expanding reimbursement coverage for the CompuFlo system? A: Eric Hines, CEO: The focus is on deepening relationships in regions with existing reimbursement, collecting data, and ensuring reimbursement processes are solid before expanding. We plan to engage Board members with expertise in reimbursement to assist in this effort. Q: Can you provide an update on the VA status and any progress in that area? A: Eric Hines, CEO: We are focusing on one VA vision in the eastern US to make progress. Each VA operates independently, so the strategy is to succeed in one area first. Neal Goldman, Chairman: Pricing is favorable for both instruments and disposables, and success in the VA could accelerate growth on the medical side. Q: What is the status of the Brazil market, and are there any plans to pursue it further? A: Neal Goldman, Chairman: Brazil remains a long-term potential, but there are no immediate developments due to recent tariffs and other challenges. The focus is on executing in existing markets before expanding to new ones like Brazil. Q: How are clinicians responding to the CompuFlo technology, and is there a plan to leverage their feedback for broader adoption? A: Eric Hines, CEO: We have an advisory group to gather insights from clinicians using the product. The focus is on understanding the pros and cons and collecting data to refine our approach before expanding to a broader market. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store